The Aerosol Therapy Market to witness an exponential spike in the next decade

Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.

Request to Sample report @ https://www.persistencemarketresearch.com/samples/11944

Aerosol therapy provides a fast and non-invasive way for treatment of lung disorders as the drug is delivered at the receptor site. Effectiveness of the therapy depends on how deeply aerosol particles infiltrate into the bronchial track and where the particles are deposited. A particle size under 2μm is ideal and can permeate up to the peripheral airways. That is why most commercially available aerosol devices produce droplets of roughly this size.

As per the World Health Organization, about half the cases of asthma and COPD are due to hereditary weakness and the other cases are due to environmental factors. The effect of pollution is likely to intensify globally along with industrialization of areas, and increasing the number of vehicles. Current government activities and rising healthcare investments are drivers of aerosol therapy market, which would upgrade over the examination time frame. Increasing prices are major factor that is restraining the growth of the market in terms of value.

How the Coronavirus Threat has Taken Global Business into Uncharted Waters

The global market for aerosol therapy is segmented on the basis of product type, technology, disease indication, end user and geography:

  • Segmentation by product type:
    • Inhalers
      • Dry Powder Inhalers (DPIs)
      • Metered Dose Inhalers (MDIs)
    • Nebulizers
      • Ultrasonic Nebulizer
      • Compressed Air-Jet nebulizers
      • Vibrating membrane device
    • Bronchodilators
  • Segmentation by technology:
    • Manually operated
    • Digitally operated
  • Segmentation by disease indication:
    • Asthma
    • COPD
    • BPD
    • Other
  • Segmentation by end user:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Individual

Request For TOC @ https://www.persistencemarketresearch.com/toc/11944

Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.

On the basis of regional presence, global aerosol therapy market is segmented into five key regions viz.  North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. Asthma symptoms were detected in 26 million persons who live in the U.S., of which, 19 million comprise adults and 7 million comprise children. With this rate, North America is expected to dominate the market. Asia Pacific (mostly China and India) market is estimated to grow at a relatively fast rate over the forecast period.

The largest manufacturers of aerosol therapy devices are ,

  • Merc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline
  • AstraZeneca Plc
  •  SmithKline Beecham 
  • GlaxoSmithKline,
  • Novartis AGTeva Pharmaceuticals,
  • Opko Health
  • Omron Healthcare Co
  • Covidien plc
  • GE Healthcare Ltd.
  • Philips Healthcare
  • Agilent Technologies, Inc. Ltd
  • GF Health Products, Inc.

For in-depth competitive analysis, buy now@ https://www.persistencemarketresearch.com/checkout/11944

Explore Extensive Coverage of PMR`s 

Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Recommended For You

About the Author:

Leave a Reply

Your email address will not be published. Required fields are marked *